UK markets closed
NIKKEI 225
38,079.70 +117.90 (+0.31%) HANG SENG
16,385.87 +134.03 (+0.82%) CRUDE OIL
82.77 +0.08 (+0.10%) GOLD FUTURES
2,396.40 +8.00 (+0.33%) DOW
37,774.40 +21.09 (+0.06%) Bitcoin GBP
50,386.80 +828.64 (+1.67%)
Mayne Pharma Group Limited (HG6.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 08:02AM CEST. Market open.
| Previous close | 3.9800 |
| Open | 4.0200 |
| Bid | 4.0200 x 1000000 |
| Ask | 4.1000 x 1000000 |
| Day's range | 4.0200 - 4.0200 |
| 52-week range | 1.6300 - 4.3600 |
| Volume | |
| Avg. volume | 12 |
| Market cap | 345.517M |
| Beta (5Y monthly) | 1.32 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 18 Jan 2023 |
| 1y target est | N/A |
- GlobeNewswire
Mayne Pharma to Present at the 42nd Annual J.P. Morgan Healthcare Conference
ADELAIDE, Australia, Dec. 29, 2023 (GLOBE NEWSWIRE) -- Mayne Pharma Group Limited (ASX: MYX) today announced that Shawn Patrick O’Brien, Chief Executive Officer of Mayne Pharma, will present at the 42nd Annual J.P. Morgan Healthcare Conference as follows: Date: Thursday, January 11, 2024Time: 7:30am PST / 10:30 am ESTWebcast: Click here The live and archived webcast of the presentation will be accessible from the Company’s website www.maynepharma.com under Investor Relations. The replay of the w
© 2024 Yahoo. All rights reserved.